Vietnam pharmaceuticals imports up 76.60 percent in March 2026 / Italy +211.19%, Germany +31.58%

Vietnam imported pharmaceuticals to the tune of US$376 million in March, up from US$212.75 million in February, a change of 76.60 percent, according to preliminary data from Vietnam’s General Department of Customs.

Year to date, Vietnam imported US$889 million worth of pharmaceuticals by the end of March.

Italy accounted for US$37 million in March, up from US$12 million in February, a 211.19 percent increase. Year to date, imports from Italy reached US$79 million.

Germany followed with US$35 million in March, up from US$27 million in February, a 31.58 percent increase. Year to date, imports from Germany totalled US$90 million.

India recorded US$33 million in March, up from US$18 million in February, an 83.63 percent increase. Year to date, imports from India reached US$71 million.

The USA posted US$31 million in March, up from US$18 million in February, a 70.90 percent increase. Year to date, imports from the USA totalled US$67 million.

France rounded out the top five with US$29 million in March, up from US$25 million in February, a 15.73 percent increase. Year to date, imports from France reached US$107 million.

Learn more about accessing Vietnam’s consumer market→

Listed pharmaceutical companies

Key pharmaceuticals firms listed on the Vietnam stock exchange include:

Ben Tre Pharmaceutical JSC (DBT)

Ben Tre Pharmaceutical JSC (DBT) produces and distributes generic drugs, supplements, and medical products across Vietnam. (DBT)

In March, DBT shares moved from 10.40 to 10.80, a change of 0.40 (3.85%).

Foreign ownership was unchanged.

Cuu Long Pharmaceutical Joint Stock Corporation (DCL)

Cuu Long Pharmaceutical Joint Stock Corporation (DCL) manufactures and distributes pharmaceutical and healthcare products under the Traphaco Group. (DCL)

In March, DCL shares moved from 55.10 to 56.10, a change of 1.00 (1.81%).

Foreign ownership was unchanged.

Imexpharm Corporation (IMP)

Imexpharm Corporation (IMP) manufactures and distributes pharmaceuticals and healthcare products nationwide. (IMP)

In March, IMP shares moved from 54.00 to 54.70, a change of 0.70 (1.30%).

Foreign ownership moved from 413,327.52 to 416,706.80, a change of 3,379.28 (0.82%).

OPC Pharmaceutical JSC (OPC)

OPC Pharmaceutical JSC (OPC) manufactures and distributes traditional and modern pharmaceutical products across Vietnam. (OPC)

In March, OPC shares moved from 22.15 to 22.30, a change of 0.15 (0.68%).

Foreign ownership was unchanged.

Traphaco JSC (TRA)

Traphaco JSC (TRA) produces and distributes pharmaceutical products, focusing on herbal and modern medicines. (TRA)

In March, TRA shares moved from 70.00 to 69.80, a change of -0.20 (-0.29%).

Foreign ownership moved from 10,963.04 to 10,938.04, a change of -25.00 (-0.23%).

Domesco Medical Import Export JSC (DMC)

Domesco Medical Import Export JSC (DMC) manufactures and distributes pharmaceuticals, supplements, and medical equipment in Vietnam. (DMC)

In March, DMC shares moved from 61.00 to 58.90, a change of -2.10 (-3.44%).

Foreign ownership moved from 150,337.50 to 150,340.59, a change of 3.09 (0.00%).

DHG Pharmaceutical Joint Stock Company (DHG)

DHG Pharmaceutical Joint Stock Company (DHG) manufactures, markets, and distributes branded generic drugs and healthcare products nationwide. (DHG)

In March, DHG shares moved from 104.60 to 100.90, a change of -3.70 (-3.54%).

Foreign ownership moved from 601,674.11 to 601,709.11, a change of 35.00 (0.01%).

Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company (DBD)

Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company (DBD)

In March, DBD shares moved from 54.30 to 51.70, a change of -2.60 (-4.79%).

Foreign ownership moved from 798,867.61 to 799,473.11, a change of 605.50 (0.08%).

FIT Group JSC (FIT)

FIT Group JSC (FIT) operates as a diversified holding company investing in pharmaceuticals, beverages, and consumer goods. (FIT)

In March, FIT shares moved from 4.69 to 4.27, a change of -0.42 (-8.96%).

Foreign ownership was unchanged.

Explore opening a trading account in Vietnam→

Vietnam’s pharmaceuticals industry

Vietnam’s pharmaceutical industry is expanding rapidly, supported by rising healthcare demand, an ageing population, and increasing incomes.

The market remains reliant on imported drugs and raw materials, although domestic manufacturers are scaling up production and upgrading standards.

Foreign firms play a significant role through imports, distribution partnerships, and investment, particularly in high-value and specialised medicines.

Regulatory reforms, hospital procurement policies, and price controls continue to shape competition, market access, and industry growth.

Learn more about starting a business in Vietnam→

The data

Vietnam imports of pharmaceuticals in March, 2026 US$m